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Summary
. Data are presented from the ﬁfth combined vascular
and peritoneal dialysis (PD) access audit.
. In 2015, 53 of 62 centres in England, Wales and
Northern Ireland returned data on ﬁrst access for
4,032 incident haemodialysis (HD) and 1,075 inci-
dent PD recipients.
. Of the 5,107 incident patients, 21.0% started PD,
30.3% started HD with an arteriovenous ﬁstula
(AVF) or graft (AVG), 28.7% with a tunnelled line
(TL) and 19.9% with a non-tunnelled line (NTL).
. Wide variation in deﬁnitive access use (deﬁned as
primary AVF, AVG or PD) was apparent between
centres.
. Only 10 centres achieved the 60% target for AVF/
AVG use amongst incident HD recipients.
. Seventeen centres achieved the 80% target for AVF/
AVG/PD use amongst prevalent dialysis recipients.
. Timely presentation to a nephrologist and referral to
a dialysis access surgeon were key determinants of
the likelihood of deﬁnitive access:
– 60.0% of patients known to a nephrologist for
over 90 days initiated dialysis with deﬁnitive
access compared with 15.2% of those who were
known to a nephrologist for 90 days or less.
– Among incident HD patients who were reviewed
by a surgeon three months prior to starting
dialysis, AVF/AVG use was 70.9% compared
with 10.0% in those who were not.
. AVF/AVG use amongst incident HD recipients
increased with rising age and body mass index
(BMI). This was due to lower rates of PD and pre-
emptive transplant (PTx) amongst older patients
and the obese.
. In centres that placed non-surgical PD catheters,
25.9% of incident renal replacement therapy (RRT)
patients started PD, compared with 21.0% overall.
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. For centres returning data on one-year PD access
outcomes, 76.6% of patients starting PD continued
to use this modality one year later after censoring
for death, withdrawal from dialysis and trans-
plantation.
. The median one-year PD catheter failure rate was
13.3%.
. This report demonstrates wide variation in practice
between centres across several domains in the pro-
vision of dialysis access. Further work is required
to understand the underlying reasons.
Introduction
Provision of deﬁnitive dialysis access is an important
measure of good clinical care for patients with established
renal failure. Relevant recommendations and audit stan-
dards are presented in the Renal Association clinical
practice guidelines (table 12.1). The annual multisite
dialysis access audit provides centre-level information
on access provision in England, Wales and Northern
Ireland. Although the Renal Association undertook a
national vascular access audit in 2005, published with
outcomes data in 2012 by the UK Renal Registry
(UKRR) [1], this is the ﬁfth annual audit that combines
peritoneal and vascular access, presenting information
for patients starting dialysis between 1st January and
31st December 2015.
One objective of this audit has been to highlight
centre-level performance variation and explore factors
that may contribute to the provision of high quality
vascular and peritoneal access. For the 19th Annual
Report, this chapter is expanded to allow more detailed
examination of dialysis access patterns through the
incorporation of UKRR data. The resulting improved
data completeness allowed more detailed analysis and
data presentation, for example, permitting analysis of
the relationship between dialysis access and PTx. The
chapter is presented in two parts: part 1 presents
detailed data from the ﬁfth multisite dialysis access
Table 12.1. Summary of relevant audit standards stated in the Renal Association (RA) clinical practice guidelines
RA audit measure/guideline∗ Reported Notes
1 Proportion of planned renal replacement therapy initiations with established
access or pre-emptive transplantation (no minimum audit standard)
Yes Table 12.3
Table 12.4
Table 12.9
Table 12.10
2 60% of all incident patients with established end stage kidney disease
commencing planned haemodialysis should receive dialysis via a functioning
arteriovenous ﬁstula or arteriovenous graft
Yes Table 12.3
Table 12.4
Table 12.9
Table 12.10
Figure 12.9
3 80% of all prevalent long-term dialysis patients should receive dialysis
treatment via ‘deﬁnitive access’: arteriovenous ﬁstula, arteriovenous graft or
peritoneal dialysis
Yes Figure 12.11
Table 12.10
4 Catheter patency – more than 80% of catheters should be patent at one year
(censoring for death and elective modality change)
Yes Figure 12.17
Figure 12.19
5 Complications following peritoneal dialysis catheter insertion: Partly Figure 12.18
Figure 12.19
5a Bowel perforation ,1% No Not captured by the audit
5b Signiﬁcant haemorrhage ,1% No Not captured by the audit
5c Exit site infection within two weeks of catheter insertion ,5% No Not captured by the audit
5d Peritonitis within two weeks of catheter insertion ,5% No Low data completeness
5e Functional catheter problem requiring manipulation or replacement or leading
to technique failure ,20%
No Not captured by the audit
∗Audit standards from the most recent Renal Association guidelines (June 2017) are presented. Current and previous guidelines are available
on the Renal Association website (http://www.renal.org/guidelines/current-guidelines)
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audit; and part 2 presents summary data over the
ﬁve years since the annual collection was started in
2011.
The term ‘established renal failure’ used within this
chapter is synonymous with the terms ‘end stage renal
failure’ and ‘end stage kidney disease’. These alternative
terms are in widespread international use, but are less
acceptable to patients.
Methods
In 2016, all adult renal centres in England, Wales and Northern
Ireland were asked to provide vascular and peritoneal access data
for incident (1st January to 31st December 2015) and prevalent
dialysis patients. Access data for incident patients were collected
at patient level, whereas centre-level data were submitted for
prevalent patients. Table 12.2 presents a full glossary of collected
variables. Data were collected using Microsoft Excel spreadsheets
circulated by the UKRR.
Table 12.2. Glossary of variables collected in the 2015 multisite dialysis access audit
Audit data item Deﬁnition [format] PD/HD or both
ID Local hospital number [numerical] Both
NHS number NHS number (England & Wales) [numerical] Both
Surname [text] Both
Forename [text] Both
DoB Date of birth [DD/MM/YY] Both
Gender [Male/Female/Unknown] Both
Date of death [DD/MM/YY] Both
Postcode The postcode of the patient’s usual address [alpha-numerical] Both
First RRT treatment centre code Renal treatment centre where ﬁrst dialysis took place
[treatment centre ID code]
Both
Primary renal diagnosis Primary renal diagnosis [EDTA four digit diagnosis code] Both
BMI BMI at time of access insertion (weight in kg/height in m2)
[numerical]
Both
Date ﬁrst seen by renal physician The date the patient was ﬁrst seen by a renal physician
(as an outpatient or inpatient) [DD/MM/YY]
Both
Assessed by surgeon for an AVF, AVG or PD
catheter at least three months before dialysis?
Was the patient assessed by a surgeon regarding dialysis
access at least three months before their ﬁrst dialysis date?
[Yes/No]
Both
Was an AVF/AVG attempted before 1st dialysis? Was an AVF/AVG attempted before the ﬁrst ever dialysis
session? [Yes/No/Unknown]
Both
Date FIRST EVER dialysis session Date of ﬁrst ever dialysis session [DD/MM/YY] Both
First ever modality First ever renal replacement modality [HD/PD] Both
Access in use at ﬁrst ever dialysis Dialysis access in use at ﬁrst dialysis (may not be ﬁrst access
created) [AVF/AVG/vein loop/TL/NTL/PD/temporary
PD catheter]
Both
Access in use at three months Dialysis access in use three months after the start of ﬁrst
treatment [AVF/AVG/vein loop/TL/NTL/PD/temporary
PD catheter/recovered/transplant/conservative/death/lost to
follow-up/transferred out]
Both
Date of ﬁrst ever access insertion/construction Date of creation/insertion of ﬁrst ever dialysis access (if
Moncrief PD catheter, date of externalisation) [DD/MM/YY]
Both
Diabetes at time of access creation Does the patient have diabetes mellitus (type 1 or 2) at time
of dialysis access creation? [Yes/No]
Both
PD catheter insertion technique Technique used to insert PD catheter
[open/laparoscopic/peritoneoscopic/percutaneous]
PD only
Peritonitis episode Peritonitis episode within two weeks of insertion? [Yes/No] PD only
Access complication Reason for access failure/discontinuation [selection from
27 item list]
Both
Date of access failure/discontinuation Date access is no longer usable for treatment [DD/MM/YY] Both
Comments Any relevant comments [text] Both
RRT – renal replacement therapy; BMI – body mass index; HD – haemodialysis; PD – peritoneal dialysis; AVF – arteriovenous ﬁstula;
AVG – arteriovenous graft; TL – tunnelled line; NTL – non-tunnelled line
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Records were validated against the UKRR database to conﬁrm
that the population collected at each centre for the audit was the
same as, or representative of, the incident population at that centre
collected via the routine quarterly return. Data checks were made
by cross-referencing with the UKRR database. Any patients
identiﬁed from the UKRR as not incident to dialysis between
1st January 2015 and 31st December 2015 were excluded. For
the purposes of this audit, patients were categorised as having
acute kidney injury (AKI) if their access at three months was
recorded as ‘recovered renal function’ and were therefore excluded
from analysis. Patients with missing information for access at start,
age and date of starting RRT were excluded from the analysis.
Patients were excluded when there was no matching record in
the UKRR database (patient assumed to be AKI) and when aged
,18 years. If a centre reported prevalent numbers that differed
by more than 10% from those in the UKRR database, it was
excluded. Cross-referencing also enabled ascertainment of
mortality within three months of commencing dialysis.
Patients starting HD were grouped by type of ﬁrst vascular
access: arteriovenous ﬁstula, arteriovenous graft, tunnelled dialysis
line, non-tunnelled dialysis line. Patients starting PD were
categorised by the insertion technique: open surgery, laparoscopic,
peritoneoscopic or percutaneous. Access at three months was
deﬁned as the type of access in use at three months after starting
dialysis. If a patient was no longer receiving dialysis at three
months (but had not recovered renal function), the reason was
recorded instead, for example, ‘death’ or ‘transplantation’. Referral
time was deﬁned as the number of days between the date of
ﬁrst being seen by a renal physician (as an inpatient or out-
patient) and the date of commencing dialysis. A patient was classi-
ﬁed as presenting ‘late’ if they had a referral time of less than
90 days.
Access failure was deﬁned when it was no longer usable for
dialysis with the date and cause of access failure reported. For
the purposes of analysis, HD access failure was grouped into ﬁve
causes: maturation, mechanical, infection, other and unknown.
PD technique failure was grouped into six causes: infection,
catheter related, solute/water clearance, leaks/hernia, other and
unknown. Access failure was censored for death, transplantation,
withdrawal from RRT and elective switching of access type. It
was the intention to only capture access failures relating to the
ﬁrst access that was performed. If the reason recorded for access
failure was not related to the ﬁrst type of access recorded, then
the data were not included in this analysis.
Centres that reported data on PD patients in the 2014 vascular
and peritoneal access audit were asked to complete a one year
follow-up of their PD patients. Additional information was
requested on the date of PD catheter failure, the reason for catheter
failure, the number of catheters used during the year and the
modality in use at one year after starting PD. Analyses that use
these data are titled ‘PD follow-up audit’.
For the ﬁrst time this chapter includes data for PTx recipients.
This reﬂects the amended (2015) Renal Association guidelines for
planned RRT initiation, which include PTx in the audit standard
(table 12.1). Where possible, these data have been included at
centre level to aid in the interpretation of the effects of PTx
upon rates of deﬁnitive and non-deﬁnitive dialysis access.
Transplant and non-transplant centres work together to prepare
patients for PTx, but for the purpose of these analyses, patients
have been allocated to their most likely treatment centre
(transplant or non-transplant) using the approach of Judge et al.
[2]; this is based on patient postcode and the likelihood of receiv-
ing care in a centre.
Separate and combined analyses were performed for incident
HD and PD patients as appropriate. Due to the exploratory nature
of the audit the analyses have been limited to descriptive statistics
of frequencies, percentages and unadjusted associations between
variables. Centre-to-centre performance comparisons are made
in the context of varying patient demography, case mix and
volume. If a centre had .50% missing returns for a particular
data ﬁeld, then all patients from that centre were excluded from
analyses involving that data ﬁeld. The data were analysed using
SAS 9.3.
Part 1 – Results from the 2015 Multisite
Dialysis Access audit
Of 62 centres contacted, 53 returned data on ﬁrst
dialysis access and data from 52 centres were used.
After individual patient exclusions, 5,107 patients were
included, comprising 4,032 starting HD and 1,075 start-
ing PD (ﬁgure 12.1, table 12.3). UKRR 2015 incident
Total number of incident patients in 
Dialysis Access audit
6,427 (53 centres) 
Total number of incident dialysis 
patients  included in analysis
5,107 (52 centres) 
Centre exclusions:
MRI, 29 patients
Total number of incident dialysis 
and pre-emptive transplant patients 
(405 pre-emptive transplants)
5,394 (51 centres) * 
Patient exclusions:
7 duplicate patients
744 patients did not match to the 
UKRR data
473 patients recovered by 3 months
60 patients did not have data for 
access at start
7 patients were aged <18 years
*Cambridge excluded as patient level data  for pre-emptive
transplants in 2015 were not submitted to the UKRR
Fig. 12.1. STROBE ﬂow diagram of patients included in the 2015
Multisite Dialysis Access audit
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Table 12.3. Demographics and characteristics of patients in the 2015 Multisite Dialysis Access audit, stratiﬁed by ﬁrst dialysis
access type
HD patients % PD patients %
Variable N
AVF/
AVG TL NTL N
Open
surgery
Laparo-
scopic
Peritoneo-
scopic
Percuta-
neous Missing Total N
Total patients
Number 4,032 1,549 1,467 1,016 1,075 397 196 9 269 204 5,107
Percentage 38.4 36.4 25.2 36.9 18.2 0.8 25.0 19.0
Age at ﬁrst dialysis (years)
Median (IQR) 68 (55,76) 68 (57,77) 66 (52,75) 69 (55,77) 60 (48,73) 60 (48,73) 57 (46,72) 69 (63,71) 61 (49,73) 61 (50,71) 66 (53,76)
,45 473 29.2 44.2 26.6 214 36.0 22.4 0.5 22.9 18.2 687
45–54 550 37.1 41.5 21.5 211 39.3 19.9 25.1 15.6 761
55–64 757 39.8 35.5 24.7 221 34.4 14.9 1.4 25.8 23.5 978
65–74 1,092 41.5 35.1 23.4 224 37.9 16.5 1.3 23.2 21.0 1,316
75+ 1,160 39.1 32.6 28.4 205 37.1 17.6 1.0 28.3 16.1 1,365
BMI
,20 117 17.1 50.4 32.5 30 50.0 16.7 3.3 26.7 3.3 147
20–24 495 40.8 35.8 23.4 170 42.4 25.3 2.4 19.4 10.6 665
25–29 625 43.2 33.8 23.0 187 49.2 19.8 1.1 19.3 10.7 812
30–34 430 45.1 37.7 17.2 120 48.3 28.3 1.7 15.0 6.7 550
35+ 361 52.9 32.7 14.4 57 61.4 12.3 14.0 12.3 418
No data 537 28.3 36.1 35.6 115 27.8 20.9 37.4 13.9 652
PRD
DM 1,133 41.1 39.6 19.2 269 32.7 14.1 0.7 27.9 24.5 1,402
GN 428 39.3 40.9 19.9 189 31.7 25.9 25.9 16.4 617
HTN 258 44.2 31.8 24.0 88 35.2 22.7 3.4 26.1 12.5 346
Other 785 19.7 35.0 45.2 133 39.8 16.5 2.3 21.1 20.3 918
PKD 183 70.5 21.9 7.7 94 45.7 20.2 19.1 14.9 277
Pyelo 226 49.1 30.5 20.4 59 44.1 16.9 22.0 16.9 285
RVD 248 44.0 31.9 24.2 50 48.0 18.0 20.0 14.0 298
Uncertain 552 39.1 41.1 19.7 150 33.3 14.0 31.3 21.3 702
No data 219 44.0 31.9 24.2 43 34.1 11.0 24.4 30.5 262
Referral time (days)
,90 653 4.6 40.9 54.5 82 34.1 11.0 24.4 30.5 735
90–180 215 23.7 45.6 30.7 46 32.6 19.6 23.9 23.9 261
180–365 337 30.3 47.8 22.0 87 43.7 20.7 17.2 18.4 424
365+ 2,552 52.1 31.4 16.5 813 36.9 18.7 1.1 26.2 17.1 3,365
No data 275 13.5 50.5 36.0 47 34.0 17.0 21.3 27.7 322
Assessed by surgeon
Yes 1,825 70.4 22.6 7.0 462 35.7 25.5 1.5 22.5 14.7 2,287
No 1,768 7.4 49.7 42.9 433 45.5 13.2 0.5 35.6 5.3 2,201
No data 73 8.2 42.5 49.3 68 36.8 2.9 16.2 44.1 141
Gender
Female 1,480 37.2 38.0 24.8 404 35.6 22.0 1.2 23.3 17.8 1,884
Male 2,552 39.1 35.4 25.4 671 37.7 15.9 0.6 26.1 19.7 3,223
Ethnicity
Asian 541 39.4 40.1 20.5 134 24.6 14.9 0.7 23.9 35.8 675
Black 317 28.1 45.7 26.2 77 13.0 16.9 26.0 44.2 394
Other 121 37.2 38.0 24.8 44 9.1 25.0 2.3 15.9 47.7 165
White 2,761 40.3 33.5 26.3 788 43.1 19.0 0.9 24.9 12.1 3,549
No data 186 29.6 34.9 35.5 20 35.0 10.0 25.0 30.0 206
eGFR at start
Median (IQR) 8 (6,10) 9 (7,10) 8 (6,10) 9 (6,11) 8 (7,10) 9 (7,11) 8 (7,10) 9 (7,10) 8 (6,10) 9 (7,11) 8 (7,10)
Diabetes
Yes 1,564 40.5 38.2 21.3 340 37.4 16.2 0.9 25.0 20.6 1,904
No 1,954 37.7 36.1 26.2 597 40.9 20.9 1.0 24.1 13.1 2,551
No data 188 20.7 23.4 55.9 56 7.1 92.9 244
Centres with .50% missing data for a variable were excluded from summary data and analyses relating to that variable, hence the total number of patients
does not always sum to the total
IQR – interquartile range; BMI – body mass index; PRD – primary renal diagnosis; DM – diabetes mellitus; GN – glomerulonephritis; HTN – hypertension;
PKD – polycystic kidney disease; Pyelo – pyelonephritis; RVD – renal vascular disease; HD – haemodialysis; PD – peritoneal dialysis; eGFR – estimated
glomerular ﬁltration rate; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line; NTL – non-tunnelled line
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data for centres submitting data were 3,968 HD and 1,076
PD patients. The slight over-reporting represents the
inability to check all patients against the UKRR dataset,
because some centres did not provide patient-level data.
It is also possible that a small number of patients with
AKI remained in the audit data on account of incomplete
data at three months. Furthermore, it is possible that
some patients who were excluded because they did not
match to the UKRR database did not have AKI, but
instead started dialysis towards the end of 2015 and the
UKRR has not yet received data from renal centres.
Data completeness
Data completeness varied between 100% (date of birth,
gender, dialysis start date, ﬁrst dialysis access and ﬁrst
dialysis modality) and 27.3% (date of access failure).
The data on diabetes were supplemented by triangulation
with UKRR comorbidity and primary renal diagnosis
(PRD), increasing completeness of diabetic status data
from 78.2% to 89.9%. Of 51 centres that reported data
on PD patients in 2014 (N = 1,069), 43 completed the
one year follow-up, returning data on 834 (78.0%)
patients. In these patients, 487 (58.4%) were still on PD
at one year with 76.8% of these (374/487) still on their
ﬁrst catheter.
Variations in ﬁrst dialysis access
The following observations can be made of incident
dialysis access. These represent associations and do not
imply causality. Data were unadjusted for patient factors.
. 51.4% of dialysis patients started therapy using an
AVF/AVG or a PD catheter.
. 38.4% of HD patients started therapy using an AVF
or AVG.
. AVF use increased with increasing referral time,
with corresponding reductions in TL/NTL use:
45.2% of incident HD patients known to a neph-
rologist for over 90 days had an AVF/AVG which
was below the Renal Association Audit standard of
60% (table 12.1).
. AVF use increased with increasing age and BMI,
with corresponding reductions in TL/NTL use.
. AVG use was uncommon; used in only 0.9% of
incident dialysis patients.
. Percutaneous PD catheter placement was less
common with increasing BMI.
. Use of deﬁnitive access was high (80.5%) for
patients with polycystic kidney disease listed as
their PRD (AVF 45.9%; AVG 0.7%; PD 33.9%).
There were corresponding low rates of TL/NTL
use. For patients with ‘other’ listed as their PRD,
AVF use was particularly low (16.9%).
. Incident HD patients who had been reviewed by a
surgeon at least three months prior to starting
dialysis had higher AVF/AVG (70.4% vs 7.4%)
and lower TL/NTL use (29.6% vs 92.6%) than
those who had not.
. Black patients starting HD had lower rates of AVF/
AVG use (28.1%) than average (38.4%).
Figures 12.2–12.7 assist interpretation of table 12.3 by
including annual transplant data. Transplant data were
included to provide a more complete depiction of
incident RRT patterns. Data remained otherwise unad-
justed. For a more detailed analysis of transplantation,
see chapters 3 and 11 of this Annual Report. Data were
plotted and stratiﬁed by age (ﬁgure 12.2), BMI
(ﬁgure 12.3), PRD (ﬁgure 12.4), referral time (ﬁgure 12.5),
diabetic status (ﬁgure 12.6) and surgical referral
(ﬁgure 12.7). Centres with .50% missing data for a
variable were excluded, as detailed in the ﬁgure legend.
BMI data on PTx recipients are not presented due to
low data returns, although it is recognised that very few
transplant recipients will have BMI .35. Transplant
data were not presented against surgical referral data
because all patients who received a PTx will have received
surgical review. HD and PD data are displayed separately
in ﬁgure 12.7 because the surgical pathways for vascular
and PD access differ. Late presenting patients were
excluded from this analysis. The following observations
can be made:
. Rising use of AVF/AVG with increasing age was
associated with falling rates of transplant and PD.
. Amongst incident RRT patients with BMI ,20, PD
use was low (20.4%) and TL/NTL use was high
(66.0%). Otherwise the rising use of AVF/AVG
with increasing BMI was associated with falling
rates of PD.
. PRD had a variable association with use of deﬁnitive
dialysis access and PTx. For example, for polycystic
kidney disease both deﬁnitive dialysis access (60.4%)
and PTx (24.3%) were common. Where PRD was
listed as ‘other’, deﬁnitive dialysis access (29.7%)
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(N = 815)
45–54
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(N = 1,054)
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(N = 1,327)
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Fig. 12.2. Percentage of incident RRT
patients by age group, 2015
Number of patients in each group in brackets.
PTx – pre-emptive transplant; PD – peritoneal
dialysis; AVF – arteriovenous ﬁstula;
AVG – arteriovenous graft; TL – tunnelled line;
NTL – non-tunnelled line
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Fig. 12.3. Percentage of incident dialysis
patients by BMI group, 2015
Number of patients in each group in brackets.
15 centres were excluded due to .50% missing
BMI data.
PD – peritoneal dialysis; AVF – arteriovenous
ﬁstula; AVG – arteriovenous graft; TL – tunnelled
line; NTL – non-tunnelled line; BMI – body mass
index
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Fig. 12.4. Percentage of incident RRT
patients by primary renal diagnosis, 2015
Number of patients in each group in brackets.
PRD groups are sorted by decreasing proportion
of patients initiating RRT with a HD catheter.
PRD – primary renal diagnosis; DM – diabetes
mellitus; GN – glomerulonephritis; HTN –
hypertension; PKD – polycystic kidney disease;
Pyelo – pyelonephritis; RVD – renal vascular
disease
PTx – pre-emptive transplant; PD – peritoneal
dialysis; AVF – arteriovenous ﬁstula;
AVG – arteriovenous graft; TL – tunnelled line;
NTL – non-tunnelled line
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Fig. 12.5. Percentage of incident RRT
patients by late presentation group, 2015
Number of patients in each group in brackets.
PTx – pre-emptive transplant; PD – peritoneal
dialysis; AVF – arteriovenous ﬁstula;
AVG – arteriovenous graft; TL – tunnelled line;
NTL – non-tunnelled line
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Fig. 12.6. Percentage of incident RRT
patients by diabetic status, 2015
Number of patients in each group in brackets.
Two centres were excluded due to .50% missing
diabetes data after triangulation with UKRR data
PTx – pre-emptive transplant; PD – peritoneal
dialysis; AVF – arteriovenous ﬁstula;
AVG – arteriovenous graft; TL – tunnelled line;
NTL – non-tunnelled line
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Fig. 12.7. Percentage of incident dialysis
patients stratiﬁed by assessment by a
surgeon within 3 months before starting
RRT and access at start of dialysis, 2015
Number of patients in each group in brackets.
Late presenting patients were excluded from the
analysis
AVF – arteriovenous ﬁstula; AVG –
arteriovenous graft; TL – tunnelled line; NTL –
non-tunnelled line; PD – peritoneal dialysis
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and PTx (5.5%) were both uncommon. In reno-
vascular disease deﬁnitive dialysis access was estab-
lished in 52.6% of incident patients, whilst PTx was
very rare (1.7%).
. Increasing referral time was associated with a
gradual increase in AVF/AVG, PD and PTx use,
with corresponding reductions in use of TL/NTL.
This pattern continued as referral time increased
beyond 365 days.
. 63.5% of incident RRT patients known to a nephrol-
ogist for over 90 days had deﬁnitive access or a
transplant. Whilst the Renal Association present
this as an audit standard, no minimum standard is
set (table 12.1).
. PD was initiated for only 11.1% of late presenta-
tions.
. Patients with diabetes were more likely to use an
AVF/AVG and less likely to receive PTx or PD
than patients without diabetes.
. AVF/AVG use was much higher amongst haemo-
dialysis recipients referred to a surgeon .90 days
before dialysis initiation (70.9%) than those who
were not (10.0%).
Variations in ﬁrst dialysis access by renal centre
Figure 12.8 plots incident RRT ﬁrst access method
stratiﬁed by centre. Practice variation was apparent.
Initiating HD via an AVF/AVG ranged between ,15%
(London West, Carlisle) and .40% (Cardiff, Shefﬁeld,
Gloucester, York, Colchester). Initiating HD via a TL
ranged between ,5% (Belfast) and .40% (London
West, Colchester, West NI). Initiating with a PD catheter
ranged between 0% (Clwyd, Colchester, Plymouth) and
.40% (Derby, Newry, Carlisle). There does not seem
to be a relationship between the rate of deﬁnitive access
use and whether a centre is a transplant or non-
transplanting centre.
Table 12.4 provides centre-level data for incident
dialysis access, grouping patients by time of presentation
to nephrology (early590 or late,90 days before initiat-
ing dialysis). Late presentation was associated with low
rates of deﬁnitive access placement (15.3%). Peritoneal
catheter placement accounted for 73.2% of deﬁnitive
access placed in late presenting patients. Sixteen centres
had no late presenting patients dialysing with deﬁnitive
access at initiation. Some centres were able to establish
deﬁnitive vascular access for late presenting patients,
although absolute numbers of patients were small.
Surgical referral was made 90 days or more before dialysis
initiation for 51.2% of incident patients, and ranged
between .90% (London Barts, Middlesbrough) and
,20% (Plymouth, Southend).
Table 12.5 provides centre-level data for dialysis access
three months after initiation, grouping patients by time of
initial presentation to nephrology (early 590 or late
,90 days before initiating dialysis). Late presentation
remained associated with low rates of deﬁnitive access
use at three months (15.2%) compared with early presen-
tation (60.0%). TL was the mode of access for 62.4% of
late presenting patients at three months. Deﬁnitive access
was similar at initiation and three months later for late
presenters and early presenters. Of early presenters,
1.8% were transplanted by three months with an overall
fall in use of NTLs amongst this group. Of late presenting
patients, 0.1% were transplanted by three months. Sixteen
centres had no late presenting patients dialysing with
deﬁnitive access at three months. A small number of
centres were able to establish deﬁnitive access in at least
40% of late presenting patients by three months
(Derby, London St George’s, Cardiff ).
Table 12.6 shows dialysis access three months after
initiation, stratiﬁed by ﬁrst access type. The shaded cells
highlight proportions of patients who continued to use
their initial dialysis access at three months. Of patients
who initiated dialysis with deﬁnitive access, 86.2%
continued with the same access at three months and
88.2% had deﬁnitive access or a transplant, whilst 5.9%
converted to TL/NTL. Of patients who started dialysis
without deﬁnitive access, 12.8% received a transplant or
were dialysing with deﬁnitive access at three months.
Of patients who initiated dialysis with a TL, 78.9%
continued with a TL at three months and only 12.9%
had converted to deﬁnitive access or a transplant.
Death before three months was much more common in
patients initiating dialysis with a NTL than with any
other form of initial access (22.5%). Of those patients
who initiated dialysis with a NTL and survived to three
months, 78.3% converted to a TL.
Figure 12.9 provides a funnel plot of the percentage of
patients starting HD with an AVF or AVG. Late present-
ing patients were excluded as a surrogate for ‘unplanned
dialysis initiation’ as per the Renal Association guidelines
(table 12.1). This analysis shows that the majority of UK
renal centres fell below the Renal Association audit
standard of 560% AVF/AVG use at ‘planned’ HD
initiation. Only ten centres achieved the target. All
these centres had ,65 incident HD patients, although
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Fig. 12.8. Incident RRT ﬁrst access method for patients in the 2015 Multisite Dialysis Access audit, stratiﬁed by renal centre
Centre size (patient numbers) in brackets. Centres are stratiﬁed by transplanting/non-transplanting centre and sorted by proportion of patients initiating
RRT with a HD catheter (TL/NTL). PTx – pre-emptive transplant; PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft;
TL – tunnelled line; NTL – non-tunnelled line; RRT – renal replacement therapy
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Table 12.4. Modality at start of dialysis and access in use for patients in the 2015 Multisite Dialysis Access audit, by early and late
presentation at dialysis initiation, by centre, including surgical referral rates within three months before start of dialysis
Early presenters (590 days before
start of dialysis) %
Late presenters (,90 days before
start of dialysis) %
Surgical
assessment %
Treatment modality
at start (N)
Centre N PD
AVF/
AVG TL NTL N PD
AVF/
AVG TL NTL Yes No HD PD PTx
Total
N
Antrim 29 31.0 41.4 20.7 6.9 4 0.0 0.0 75.0 25.0 80.0 20.0 26 9 2 37
B Heart 113 23.9 39.8 9.7 26.5 2 0.0 0.0 0.0 100.0 51.3 48.7 89 28 3 120
B QEH 172 22.1 45.9 30.8 1.2 30 10.0 20.0 70.0 0.0 72.0 28.0 174 44 23 241
Bangor 27 25.9 40.7 18.5 14.8 1 100.0 0.0 0.0 0.0 75.0 25.0 20 8 0 28
Basldn 30 26.7 43.3 26.7 3.3 7 0.0 0.0 14.3 85.7 68.4 31.6 30 8 0 38
Belfast 46 23.9 41.3 2.2 32.6 13 7.7 0.0 7.7 84.6 59.7 40.3 50 12 30 92
Bradfd 71 11.3 36.6 29.6 22.5 10 10.0 0.0 20.0 70.0 56.8 43.2 72 9 5 86
Brightn 112 20.5 38.4 28.6 12.5 15 13.3 0.0 26.7 60.0 46.2 53.8 107 25 9 141
Camb 85 9.4 34.1 55.3 1.2 10 10.0 0.0 90.0 0.0 46.6 53.4 0 0 0 0
Cardff 83 25.3 53.0 21.7 0.0 5 40.0 20.0 40.0 0.0 79.1 20.9 67 23 9 99
Carlis 36 55.6 13.9 27.8 2.8 5 0.0 0.0 40.0 60.0 69.0 31.0 22 20 0 42
Clwyd 19 0.0 42.1 31.6 26.3 1 0.0 0.0 100.0 0.0 21 0 0 21
Colchr 21 0.0 61.9 38.1 0.0 1 0.0 0.0 100.0 0.0 70.4 29.6 27 0 0 27
Derby 41 48.8 43.9 2.4 4.9 5 40.0 0.0 60.0 0.0 35.4 64.6 26 22 0 48
Donc 24 33.3 54.2 8.3 4.2 7 0.0 0.0 0.0 100.0 58.8 41.2 26 8 0 34
Dorset 58 25.9 53.4 10.3 10.3 16 12.5 0.0 31.3 56.3 39.0 61.0 60 17 1 78
Dudley 45 31.1 33.3 11.1 24.4 11 18.2 0.0 0.0 81.8 35.2 64.8 40 17 0 57
Exeter 106 21.7 40.6 15.1 22.6 20 5.0 15.0 5.0 75.0 49.2 50.8 106 26 2 134
Glouc 57 33.3 45.6 17.5 3.5 3 33.3 0.0 0.0 66.7 88.7 11.3 42 20 1 63
Hull 81 39.5 27.2 30.9 2.5 23 21.7 0.0 39.1 39.1 49.6 50.4 74 39 9 122
L Barts 197 27.4 30.5 21.8 20.3 58 24.1 5.2 32.8 37.9 100.0 0.0 203 73 15 291
L Guys 131 9.9 42.0 28.2 19.8 15 0.0 0.0 33.3 66.7 45.1 54.9 140 13 22 175
L Kings 134 31.3 26.9 22.4 19.4 20 10.0 0.0 35.0 55.0 35.2 64.8 116 46 7 169
L Rfree 171 40.9 28.1 21.6 9.4 28 32.1 0.0 39.3 28.6 50.5 49.5 132 84 14 230
L St.G 49 14.3 42.9 24.5 18.4 7 0.0 42.9 28.6 28.6 67.6 32.4 70 11 10 91
L West 250 12.8 14.0 61.6 11.6 31 0.0 3.2 45.2 51.6 46.4 53.6 277 33 24 334
Leeds 98 25.5 37.8 12.2 24.5 18 22.2 0.0 5.6 72.2 42.6 57.4 93 29 25 147
Leic 193 23.8 38.9 26.9 10.4 28 3.6 14.3 60.7 21.4 59.6 40.4 179 49 23 251
Liv Ain 48 43.8 35.4 16.7 4.2 12 8.3 0.0 83.3 8.3 31.3 68.8 41 24 2 67
Middlbr 91 14.3 40.7 35.2 9.9 17 11.8 5.9 58.8 23.5 100.0 0.0 101 15 13 129
Newc 96 15.6 33.3 36.5 14.6 29 0.0 0.0 62.1 37.9 45.2 54.8 111 15 9 135
Newry 26 42.3 38.5 7.7 11.5 0 65.5 34.5 17 12 0 29
Nottm 103 28.2 40.8 13.6 17.5 16 12.5 0.0 18.8 68.8 42.7 57.3 92 31 16 139
Oxford 124 18.5 48.4 19.4 13.7 12 25.0 0.0 50.0 25.0 59.2 40.8 113 29 36 178
Plymth 19 0.0 47.4 31.6 21.1 4 0.0 25.0 0.0 75.0 0.0 100.0 33 0 11 44
Ports 115 24.3 45.2 20.0 10.4 39 7.7 12.8 33.3 46.2 50.0 50.0 147 33 14 194
Prestn 103 18.4 36.9 32.0 12.6 24 4.2 0.0 45.8 50.0 53.1 46.9 108 21 12 141
Redng 61 41.0 27.9 11.5 19.7 15 13.3 0.0 26.7 60.0 23.7 76.3 49 27 6 82
Salford 104 26.0 29.8 33.7 10.6 24 0.0 4.2 50.0 45.8 34.8 65.2 113 29 5 147
Sheff 83 19.3 45.8 31.3 3.6 1 0.0 0.0 100.0 0.0 77.4 22.6 68 16 8 92
Shrew 49 20.4 42.9 4.1 32.7 29 0.0 0.0 10.3 89.7 55.6 44.4 69 12 2 83
Stevng 83 9.6 30.1 42.2 18.1 25 0.0 0.0 44.0 56.0 44.3 55.7 108 8 9 125
Sthend 21 23.8 33.3 19.0 23.8 5 0.0 0.0 20.0 80.0 17.2 82.8 24 5 1 30
Sund 50 16.0 36.0 38.0 10.0 8 12.5 0.0 37.5 50.0 74.6 25.4 50 9 2 61
Swanse 114 17.5 37.7 14.0 30.7 29 10.3 3.4 3.4 82.8 25.3 74.7 124 23 7 154
Truro 47 14.9 36.2 36.2 12.8 18 0.0 0.0 44.4 55.6 44.9 55.1 62 7 5 74
Ulster 25 8.0 36.0 32.0 24.0 5 0.0 0.0 60.0 40.0 60.6 39.4 29 4 1 34
West NI 10 20.0 30.0 50.0 0.0 0 63.6 36.4 9 2 1 12
Wirral 46 21.7 30.4 21.7 26.1 9 11.1 0.0 33.3 55.6 32.1 67.9 45 11 1 57
Wolve 74 35.1 31.1 29.7 4.1 11 63.6 0.0 18.2 18.2 57.5 42.5 54 33 0 87
Wrexm 33 30.3 33.3 18.2 18.2 3 0.0 0.0 66.7 33.3 64.1 35.9 29 10 3 42
York 46 23.9 56.5 8.7 10.9 6 33.3 0.0 16.7 50.0 52.7 47.3 41 14 7 62
Total 4,050 23.4 36.6 26.2 13.9 735 11.2 4.1 36.3 48.4 51.2 48.8 3,926 1,063 405 5,394
PTx – pre-emptive transplant; HD – haemodialysis; PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft;
TL – tunnelled line; NTL – non-tunnelled line
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Table 12.5. Modality at three months after start of dialysis and access in use for patients in the 2015 Multisite Dialysis Access
audit, by early and late presentation at dialysis initiation, by centre
Early presenters
(590 days before start of dialysis) %
Late presenters
(,90 days before start of dialysis) % Treatment modality at 3 months (N)
Centre PTx PD
AVF/
AVG TL NTL Other Miss
Total
(N) PTx PD
AVF/
AVG TL NTL Other Miss
Total
(N) PTx PD
AVF/
AVG TL NTL Other Miss Total
Antrim 0.0 31.0 37.9 31.0 0.0 0.0 0.0 29 0.0 0.0 0.0 75.0 0.0 25.0 0.0 4 0 9 11 13 0 2 0 35
B Heart 0.9 23.9 38.9 28.3 0.0 8.0 0.0 113 0.0 0.0 0.0 100.0 0.0 0.0 0.0 2 1 28 44 35 0 9 0 117
B QEH 1.2 20.3 43.6 32.0 0.0 2.9 0.0 172 0.0 10.0 16.7 73.3 0.0 0.0 0.0 30 2 41 82 86 0 7 0 218
Bangor 3.7 18.5 33.3 40.7 3.7 0.0 0.0 27 0.0 0.0 0.0 0.0 0.0 100.0 0.0 1 1 5 9 11 1 1 0 28
Basldn 0.0 26.7 40.0 26.7 0.0 3.3 3.3 30 0.0 28.6 0.0 57.1 0.0 14.3 0.0 7 0 10 12 13 0 2 1 38
Belfast 6.5 21.7 41.3 21.7 2.2 6.5 0.0 46 0.0 23.1 0.0 23.1 0.0 53.8 0.0 13 3 14 20 14 1 10 0 62
Bradfd 2.8 11.3 40.8 40.8 1.4 2.8 0.0 71 0.0 10.0 0.0 80.0 0.0 10.0 0.0 10 2 9 29 37 1 3 0 81
Brightn 0.0 17.9 33.9 35.7 0.0 12.5 0.0 112 0.0 13.3 6.7 60.0 0.0 20.0 0.0 15 0 22 40 51 0 19 0 132
Camb 2.4 9.4 41.2 38.8 0.0 8.2 0.0 85 0.0 10.0 10.0 70.0 0.0 10.0 0.0 10 2 12 46 49 0 9 0 118
Cardff 0.0 2.4 59.0 9.6 0.0 3.6 25.3 83 0.0 0.0 40.0 20.0 0.0 0.0 40.0 5 0 2 53 9 0 3 23 90
Carlis 0.0 52.8 16.7 30.6 0.0 0.0 0.0 36 0.0 0.0 0.0 100.0 0.0 0.0 0.0 5 0 19 6 17 0 0 0 42
Clwyd 5.3 0.0 47.4 31.6 0.0 15.8 0.0 19 0.0 0.0 0.0 100.0 0.0 0.0 0.0 1 1 0 9 8 0 3 0 21
Colchr 4.8 0.0 57.1 23.8 0.0 14.3 0.0 21 0.0 0.0 0.0 100.0 0.0 0.0 0.0 1 1 0 12 11 0 3 0 27
Derby 2.4 46.3 46.3 4.9 0.0 0.0 0.0 41 0.0 40.0 40.0 20.0 0.0 0.0 0.0 5 1 21 21 4 0 1 0 48
Donc 4.2 25.0 54.2 16.7 0.0 0.0 0.0 24 0.0 0.0 0.0 85.7 0.0 14.3 0.0 7 1 6 13 13 0 1 0 34
Dorset 0.0 25.9 50.0 19.0 0.0 5.2 0.0 58 0.0 12.5 0.0 75.0 0.0 12.5 0.0 16 0 17 29 24 0 7 0 77
Dudley 0.0 35.6 26.7 24.4 2.2 11.1 0.0 45 0.0 18.2 0.0 36.4 0.0 45.5 0.0 11 0 19 12 15 1 10 0 57
Exeter 0.0 21.7 49.1 19.8 0.0 9.4 0.0 106 0.0 5.0 20.0 25.0 0.0 50.0 0.0 20 0 27 57 28 0 20 0 132
Glouc 0.0 31.6 45.6 19.3 0.0 3.5 0.0 57 0.0 0.0 0.0 100.0 0.0 0.0 0.0 3 0 18 27 15 0 2 0 62
Hull 2.5 38.3 28.4 28.4 0.0 2.5 0.0 81 4.3 26.1 4.3 56.5 0.0 8.7 0.0 23 3 38 26 42 0 4 0 113
L Barts 2.0 28.9 27.4 34.0 0.0 7.6 0.0 197 0.0 27.6 5.2 48.3 0.0 19.0 0.0 58 4 79 58 107 0 28 0 276
L Guys 6.1 9.9 37.4 42.0 0.0 4.6 0.0 131 0.0 0.0 0.0 80.0 0.0 20.0 0.0 15 8 13 50 73 0 9 0 153
L Kings 0.7 12.7 29.1 41.0 0.0 1.5 14.9 134 0.0 5.0 0.0 85.0 0.0 5.0 5.0 20 1 19 40 76 0 4 22 162
L Rfree 2.9 36.3 29.8 25.1 0.0 5.3 0.6 171 0.0 35.7 0.0 50.0 0.0 14.3 0.0 28 6 76 53 67 0 13 1 216
L St.G 0.0 16.3 42.9 28.6 8.2 4.1 0.0 49 0.0 0.0 42.9 42.9 14.3 0.0 0.0 7 0 10 26 31 7 7 0 81
L West 0.8 12.0 16.0 68.8 0.0 2.4 0.0 250 0.0 0.0 3.2 93.5 0.0 3.2 0.0 31 2 31 42 228 0 7 0 310
Leeds 3.1 24.5 41.8 22.4 0.0 8.2 0.0 98 0.0 16.7 0.0 61.1 5.6 16.7 0.0 18 3 28 42 36 1 12 0 122
Leic 2.6 16.6 37.8 35.8 0.0 7.3 0.0 193 0.0 3.6 14.3 78.6 0.0 3.6 0.0 28 5 35 78 93 0 17 0 228
Liv Ain 0.0 47.9 37.5 10.4 0.0 4.2 0.0 48 0.0 16.7 0.0 75.0 0.0 8.3 0.0 12 0 27 19 15 0 4 0 65
Middlbr 0.0 14.3 37.4 42.9 0.0 5.5 0.0 91 0.0 11.8 5.9 64.7 0.0 17.6 0.0 17 0 15 35 58 0 8 0 116
Newc 0.0 16.7 32.3 41.7 2.1 7.3 0.0 96 0.0 3.4 0.0 44.8 0.0 51.7 0.0 29 0 17 31 54 2 22 0 126
Newry 3.8 42.3 23.1 19.2 0.0 11.5 0.0 26 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 1 12 7 5 0 4 0 29
Nottm 1.9 24.3 43.7 20.4 1.0 8.7 0.0 103 0.0 6.3 0.0 43.8 0.0 50.0 0.0 16 2 26 45 30 1 19 0 123
Oxford 4.0 18.5 44.4 25.0 0.0 8.1 0.0 124 0.0 25.0 0.0 58.3 0.0 16.7 0.0 12 5 29 55 41 0 12 0 142
Plymth 0.0 0.0 63.2 21.1 0.0 15.8 0.0 19 0.0 0.0 25.0 0.0 0.0 75.0 0.0 4 0 0 14 12 0 7 0 33
Ports 3.5 18.3 47.8 27.0 0.0 3.5 0.0 115 0.0 10.3 20.5 66.7 0.0 2.6 0.0 39 4 29 67 74 0 6 0 180
Prestn 1.9 16.5 35.0 38.8 1.0 6.8 0.0 103 0.0 12.5 0.0 70.8 0.0 12.5 4.2 24 2 21 36 58 1 10 1 129
Redng 0.0 37.7 29.5 21.3 0.0 11.5 0.0 61 0.0 13.3 0.0 73.3 0.0 13.3 0.0 15 0 25 18 24 0 9 0 76
Salford 3.8 23.1 28.8 31.7 1.9 9.6 1.0 104 0.0 4.2 0.0 45.8 0.0 50.0 0.0 24 4 28 31 48 2 28 1 142
Sheff 3.6 14.5 48.2 31.3 0.0 2.4 0.0 83 0.0 0.0 0.0 100.0 0.0 0.0 0.0 1 3 12 40 27 0 2 0 84
Shrew 2.0 22.4 40.8 16.3 2.0 16.3 0.0 49 0.0 3.4 10.3 17.2 10.3 58.6 0.0 29 1 14 23 14 4 25 0 81
Stevng 3.6 9.6 36.1 39.8 0.0 10.8 0.0 83 0.0 4.0 0.0 56.0 0.0 40.0 0.0 25 3 9 30 53 0 21 0 116
Sthend 0.0 19.0 38.1 38.1 0.0 4.8 0.0 21 0.0 0.0 0.0 80.0 0.0 20.0 0.0 5 0 4 11 12 0 2 0 29
Sund 4.0 12.0 34.0 46.0 0.0 4.0 0.0 50 0.0 12.5 0.0 75.0 0.0 12.5 0.0 8 2 7 18 29 0 3 0 59
Swanse 0.0 18.4 36.8 22.8 3.5 18.4 0.0 114 0.0 10.3 3.4 41.4 0.0 44.8 0.0 29 0 24 44 39 4 36 0 147
Truro 4.3 12.8 38.3 34.0 0.0 10.6 0.0 47 0.0 0.0 0.0 77.8 0.0 22.2 0.0 18 2 6 19 32 0 10 0 69
Ulster 0.0 8.0 32.0 56.0 0.0 4.0 0.0 25 0.0 0.0 0.0 60.0 0.0 40.0 0.0 5 0 4 8 18 0 3 0 33
West NI 0.0 10.0 30.0 60.0 0.0 0.0 0.0 10 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 1 3 7 0 0 0 11
Wirral 2.2 17.4 26.1 34.8 0.0 19.6 0.0 46 0.0 11.1 0.0 44.4 0.0 44.4 0.0 9 1 9 12 20 0 14 0 56
Wolve 0.0 32.4 33.8 25.7 0.0 8.1 0.0 74 0.0 27.3 0.0 63.6 0.0 9.1 0.0 11 0 27 25 27 0 8 0 87
Wrexm 0.0 30.3 36.4 24.2 3.0 6.1 0.0 33 0.0 0.0 0.0 100.0 0.0 0.0 0.0 3 0 10 13 12 1 3 0 39
York 2.2 23.9 67.4 6.5 0.0 0.0 0.0 46 0.0 33.3 0.0 66.7 0.0 0.0 0.0 6 1 14 32 8 0 0 0 55
Total 1.8 21.3 38.7 29.9 0.6 6.7 0.9 4,050 0.1 9.8 5.4 62.4 0.6 20.7 1.0 735 78 978 1,583 1,923 27 469 49 5,107
PTx – pre-emptive transplant; PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line; NTL – non-tunnelled line; Miss – missing data
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the majority of centres of this size failed to meet the audit
standard.
Figure 12.10 depicts the percentage of incident HD
patients by ﬁrst access used, stratiﬁed by time between
date of ﬁrst access formation attempt and HD initiation.
Data from patients incident to dialysis in 2014 and 2015
are included. Date of ﬁrst access was collected for the ﬁrst
time in 2014 and has not previously been presented in
analyses in this chapter. Longer duration between ﬁrst
attempt at forming dialysis access and ﬁrst HD session
was associated with greater levels of AVF/AVG use at
initiation. Amongst patients for whom the ﬁrst attempt
at forming dialysis access was made more than one
year before starting HD, 89.0% initiated with AVF/
AVG; whereas for those patients for whom the ﬁrst
attempt at forming dialysis access was made ,90 days
before starting dialysis, 15.6% commenced HD with an
AVF/AVG. The biggest increment in deﬁnitive dialysis
Table 12.6. Dialysis access at three months since dialysis start for patients in the 2015 Multisite Dialysis Access audit, stratiﬁed by
ﬁrst access used
Access in use at
ﬁrst dialysis (N)
Access in use at three months (%)
AVF/AVG TL NTL PD catheter Transplanted Died Stopped/LTFU No data
AVF/AVG (1,549) 88.4 5.1 0.1 0.1 1.5 2.9 1.9 0.0
TL (1,467) 9.3 78.9 0.3 2.2 1.4 6.8 1.0 0.1
NTL (1,016) 7.0 60.6 1.9 5.2 0.5 22.5 1.8 0.5
PD catheter (1,075) 0.5 6.6 0.2 83.0 2.8 2.4 0.7 3.9
Shaded cells highlight the percentage of patients who remained on the same modality at three months
PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line; NTL – non-tunnelled line; LTFU –
lost to follow-up
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Fig. 12.9. Funnel plot of the percentage of HD patients in the
2015 Multisite Dialysis Access audit who commenced dialysis
with an AVF/AVG
Patients who were ﬁrst seen by a nephrologist ,90 days from initiating
dialysis were excluded. Centres with ,10 patients receiving HD were
excluded. HD – haemodialysis; AVF – arteriovenous ﬁstula; AVG – arter-
iovenous graft
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Fig. 12.10. Percentage of incident HD patients
by ﬁrst access used in the 2014 and 2015
Multisite Dialysis Access audits stratiﬁed
categorically by days (,90; 90–179; 180–364;
365+) from ﬁrst access attempt
Number of patients in each category in brackets. Late-
presenting patients were excluded from this analysis.
Three centres were excluded due to .50% missing
data for date of ﬁrst access attempt. HD –
haemodialysis; AVF – arteriovenous ﬁstula; AVG –
arteriovenous graft; TL – tunnelled line; NTL – non-
tunnelled line; Miss – missing data
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access occurred between ,90 and 590 days. Three
centres were excluded due to .50% missing data for
date of ﬁrst access attempt. Furthermore, the data ﬁeld
did not specify which access was attempted, so it cannot
be assumed that ﬁrst access attempt and access used on
ﬁrst session were the same. Missing data had a similar
distribution of access use to those seen in patients for
whom data were provided, suggesting no systematic
tendency for early or late presenting patients to be
more or less likely to have missing data.
Variations in prevalent dialysis access by renal centre
Figure 12.11 provides a funnel plot of the percentage of
prevalent dialysis patients receiving PD or HD via an
AVF/AVG. Seventeen centres met the Renal Association
audit standard of 580% for deﬁnitive access use (thick
dotted line). Thirteen centre-level exclusions were made
for this analysis due to non-completion of prevalent
dialysis access data and .10% differences between
centre-reported and UKRR numbers of patients receiving
dialysis.
Figure 12.12 depicts dialysis access for prevalent
patients by centre. Wide practice variation was apparent.
Rates of deﬁnitive access ranged between .90% (Derby,
Birmingham Heartlands, Dorset) and ,50% (London
West, Ulster). PD accounted for between.25% (Dudley,
Carlisle) and ,5% (London West, London Guys) of
prevalent deﬁnitive access use. Thirteen centre-level
exclusions were made for this analysis due to non-com-
pletion of prevalent dialysis access data and.10% differ-
ences between centre-reported and UKRR numbers of
patients receiving dialysis.
Peritoneal dialysis audit one-year follow-up by
renal centre
Figure 12.13 shows RRT modality one year after com-
mencing PD by centre. Data for this analysis came from
the 2015 one year follow-up for patients incident to
dialysis in 2014. Centres with 100% missing data at one
year, or fewer than ﬁve PD patients were excluded. The
percentage of patients remaining on PD or who were
transplanted one year after initiation ranges between
10% (Stevenage) and .85% (Cambridge, Doncaster,
Wrexham, Plymouth, Leeds, Salford) with an overall
mean of 72.8%. Of patients continuing dialysis (i.e.
censoring for death, transplant and withdrawal), 76.6%
of patients starting PD continued to use this modality
one year later.
Figure 12.14 depicts PD catheter insertion technique
stratiﬁed by centre. The ﬁve centres reporting fewer
than ﬁve patients on PD were not considered for analysis.
Surgical techniques include open and laparoscopic. Non-
surgical techniques include percutaneous and peri-
toneoscopic insertion. There was considerable practice
variation. Seventeen centres performed non-surgical PD
catheter placement, accounting for 25.9% of all catheters
placed and 13 of these centres placed .50% of their PD
catheters this way. Six placed.90% of their PD catheters
percutaneously (Southend, Gloucester, Derby, Birming-
ham Heartlands, Salford, Wolverhampton). At the 17
centres that place non-surgical PD catheters, 25.9% of
incident RRT patients started PD, compared with
21.0% overall. Approximately 48% percent of incident
RRT patients started PD at the six centres that placed
.90% of their catheters percutaneously.
Figure 12.15 displays PD catheter insertion technique
by referral time. There does not appear to be a strong
relationship between referral time and technique for
PD catheter insertion. This suggests that the PD access
referral pathway was less dependent on timely referral
than the vascular access pathway.
Figure 12.16 presents the percentage of incident PD
patients by catheter insertion technique and BMI
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Fig. 12.11. Funnel plot of the percentage of prevalent patients in
the 2015 Multisite Dialysis Access audit receiving PD or HD via
AVF/AVG
A total of 13 centre-level exclusions were made for this analysis due to
non-completion of prevalent dialysis access data and .10% differences
between centre-reported and UKRR numbers of patients receiving
dialysis. HD – haemodialysis; PD – peritoneal dialysis; AVF – arteriove-
nous ﬁstula; AVG – arteriovenous graft
282 Nephron 2017;137(suppl1):269–296 Hole/Caskey/Evans/Fluck/Kumwenda/
Steenkamp/Wilkie
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
ity
 o
f B
ris
to
l  
   
   
   
   
   
   
   
   
   
   
  
13
7.
22
2.
19
0.
63
 - 
11
/2
4/
20
17
 2
:3
3:
39
 P
M
L West  (1,514)
Ulster  (115)
Newry  (108)
Sund  (245)
Newc  (361)
L Barts  (1,227)
Middlbr  (381)
Colchr  (120)
Belfast  (205)
Bradfd  (255)
L Kings  (660)
L Guys  (713)
Carlis  (124)
Sheff  (670)
Brightn  (500)
B QEH  (1,152)
Cardff  (583)
Leic  (1,019)
Redng  (369)
Oxford  (534)
Salford  (494)
Sthend  (142)
Wrexm  (146)
L Rfree  (868)
Truro  (188)
Camb  (436)
Leeds  (570)
Bangor  (100)
Donc  (206)
Hull  (443)
Dudley  (252)
Wolve  (413)
Shrew  (242)
Nottm  (473)
York  (189)
Exeter  (528)
Dorset  (332)
B Heart  (472)
Derby  (323)
Total (17,672)
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Percentage
PD
AVF/AVG
TL/NTL
Fig. 12.12. Prevalent dialysis access by centre for patients in the 2015 Multisite Dialysis Access audit
Centre size (patient numbers) in brackets. Centres are sorted by proportion of patients initiating RRT with a HD catheter. HD – haemodialysis;
PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line; NTL – non-tunnelled line
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group. Associations between BMI and PD catheter inser-
tion technique do not appear to be strong. An open
surgical approach was used more frequently than any
other technique (43.0%). Laparoscopic surgery was used
less in patients with a BMI .35 (11.7%) and was com-
pensated by an increase in the use of open surgery
(61.7%). Rates of laparoscopic insertion were also low
amongst individuals with BMI ,20 (16.1%). This was
compensated for by greater use of open (54.8%) and
percutaneous approaches (25.8%).
Figure 12.17 shows a funnel plot of the percentage of
PD catheter failures within one year of initiating dialysis.
Data are from the one year PD follow-up audit of patients
incident to PD in 2014. PD catheter failure was censored
for transplantation, elective transfer to HD or death. Of
the 30 centres for which data were available, none were
above the 95% limit for PD catheter failure. However,
four centres were below the lower 99.9% limit, none of
which reported a failed PD catheter. The average one
year catheter failure rate of 13.3% is an improvement
on that which was reported in previous years (20.2% in
2014). Nine centres reported peritonitis within two
weeks of PD catheter insertion, with rates ranging
between 1.3% and 13.0% of inserted catheters. Twenty-
nine centres reported no cases of peritonitis within two
weeks. These results should be interpreted with caution
due to missing data and small numbers of patients in
some centres.
Figure 12.18 shows comparative access failure by
access type within three months of initiating dialysis.
Data were drawn from the 2014 and 2015 Multisite
Dialysis Access audits. Access failure was deﬁned as a
documented date of failure/discontinuation recorded
within three months of starting dialysis, unless a centre
comment indicated that it was a planned discontinuation.
Failure rates appeared higher for PD than for HD access.
Numbers of AVGs and peritoneoscopically inserted PD
tubes were very low, hence the wide conﬁdence intervals
(CIs) for these data. There was no signal from these data
to suggest that sub-types of HD or PD access were more
or less likely to fail at three months.
Figure 12.19 shows causes of PD catheter access failure
within one year of initiating dialysis in 112 catheters
reported from the one year PD follow-up audit of patients
incident to dialysis in 2014. Infection was a more frequent
cause of failure for percutaneously inserted than surgi-
cally placed PD catheters and for open compared with
laparoscopic insertion. No leaks or hernias were reported
for percutaneously inserted or failures reported in perito-
neoscopically inserted PD catheters. The relatively small
number in this analysis increases the likelihood that
differences in causes of failure between subgroups are
due to chance.
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Prestn  (25)
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Oxford  (41)
Swanse  (16)
Liv Ain  (14)
B Heart  (14)
Wolve  (29)
Carlis  (15)
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Leic  (47)
Sund  (8)
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Brightn  (29)
Redng  (31)
Derby  (27)
Wirral  (5)
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Salford  (36)
Leeds  (23)
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Wrexm  (9)
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Camb  (13)
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Fig. 12.13. Modality at one year after commencing PD in 2014,
by centre
Number of patients receiving PD at each centre in brackets. Centres with
100% missing treatment data at one year or fewer than ﬁve PD patients
were excluded. Centres are sorted by proportion of patients transplanted
or remaining on PD. PD – peritoneal dialysis; HD – haemodialysis;
Tx – transplanted
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Fig. 12.14. PD catheter insertion technique (surgical vs non-surgical) stratiﬁed by centre for patients in the 2015 Multisite Dialysis
Access audit
Number of patients receiving PD at each centre in brackets. Centres are sorted by proportion of catheters inserted by surgical technique. Centres report-
ing fewer than ﬁve patients on PD were excluded from this analysis. Due to small numbers in the subcategories of surgical insertion techniques, open and
laparoscopic insertions are grouped as ‘surgical’; peritoneoscopic and percutaneous as ‘non-surgical’. PD – peritoneal dialysis
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Missing PD tech Fig. 12.15. PD catheter insertion
technique by referral time (days) for
patients in the 2015 Multisite Dialysis
Access audit
Number of patients in each category in brackets.
Referral time was measured between ﬁrst
nephrology input (inpatient/outpatient) and
initiating dialysis. Five centres were excluded
from this analysis due to .50% missing data for
PD catheter insertion technique. PD – peritoneal
dialysis
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Fig. 12.16. Percentage of incident PD
patients by catheter insertion technique
and BMI group for patients in the 2015
Multisite Dialysis Access audit
Number of patients in each category in brackets.
Five centres were excluded from this analysis
due to .50% missing data for PD catheter
insertion technique and 15 centres due to.50%
of missing data for BMI. PD = peritoneal
dialysis; BMI = body mass index
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Fig. 12.17. Funnel plot of the percentage of PD catheter failures
within one year of start date for patients incident to PD in 2014
Thirteen centres with ,10 patients on PD were excluded from this
analysis, along with eight centres that did not return data for the one
year follow-up. PD – peritoneal dialysis
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Part 2 – Accumulated results from the 2011–
2015 annual Multisite Dialysis Access audits
Data completeness
Over the ﬁve years since the multisite access audit was
initiated, data on a total of 23,639 incident dialysis
patients have been collected. The UKRR holds data for
33,034 incident dialysis patients over this period with
patient-level data on dialysis access being available for
71.6% (table 12.7). The quality and completeness of
data have improved over the time that the annual audit
has been running (table 12.8), although the number of
centres providing data peaked in 2013. Completeness
for some ﬁelds remained lower than 75% with access
complications having particularly low levels of com-
pletion, although there is improvement here too.
Table 12.9 provides centre-level data for incident
dialysis access, grouping patients by time of presentation
to nephrology services (early590 or late,90 days before
initiating dialysis). This table reproduces table 12.4
(which includes 2015 incident patients only) for incident
dialysis patients between 2011 and 2015. Late presen-
tation remains associated with low rates of deﬁnitive
access placement compared with early presentation.
Table 12.10 provides an annual summary of rates of
incident and prevalent deﬁnitive dialysis access and
PTx. It shows that national performance from reporting
centres has consistently fallen below Renal Association
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Fig. 12.18. Percentage of patients
experiencing failure of ﬁrst access within
three months, by type of ﬁrst access, for
patients in the 2014 and 2015 Multisite
Dialysis Access audits
PD – peritoneal dialysis; AVF – arteriovenous
ﬁstula; AVG – arteriovenous graft;
TL – tunnelled line
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Fig. 12.19. Percentage of PD catheter access
failures within one year of starting dialysis, from
PD follow-up data, 2015
PD – peritoneal dialysis
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Table 12.7. Data completeness of the 2011–2015 annual Multisite Dialysis Access audits
Centre and patient reporting 2011 2012 2013 2014 2015
Centres reporting (N) 47 51 57 53 52
Incident HD patients included
N 3,412 3,522 3,696 3,945 4,032
% 80.3 77.7 78.0 78.7 79.0
Incident PD patients included
N 839 1,008 1,041 1,069 1,075
% 19.7 22.3 22.0 21.3 21.0
Reported patients excluded due to centre level exclusion (N) 0 0 0 0 29
Reported patients excluded as they did not match the UKRR data (N) 210 481 1,025 840 744
Reported patients excluded due to missing RRT start date or 1st access (N) 99 30 24 7 60
HD – haemodialysis; PD – peritoneal dialysis; RRT – renal replacement therapy; UKRR – UK Renal Registry
Table 12.8. Percentage completeness of variables in the 2011–2015 annual Multisite Dialysis Access audits
Variable 2011 2012 2013 2014 2015
Age 100.0 100.0 100.0 100.0 100.0
Gender 100.0 100.0 100.0 100.0 100.0
BMI 23.4 44.0 52.4 56.7 54.9
Diabetes at time of access creation 80.8 91.3 98.4 97.1 89.9
PRD 79.3 85.2 82.5 96.1 94.9
First RRT treatment centre 100.0 100.0 100.0 100.0 100.0
Date ﬁrst seen by renal physician 95.5 96.0 94.9 99.1 98.6
Assessed by surgeon for an AVF/AVG or PD catheter at
least 3 months before dialysis
71.7 84.9 89.3 96.8 89.6
Was an AVF/AVG attempted before 1st dialysis? 75.9 78.3
Date ﬁrst ever dialysis (HD/PD) 100.0 100.0 100.0 100.0 100.0
First ever modality (HD/PD) 100.0 100.0 100.0 100.0 100.0
Access in use at ﬁrst ever dialysis 100.0 100.0 100.0 100.0 100.0
Access in use at 3 months 87.3 94.4 99.0 97.8 99.0
Date of ﬁrst ever access insertion/construction 11.4 65.1 70.5 75.6 75.0
PD catheter insertion technique 87.8 80.2 82.7 86.3 81.0
Peritonitis 82.7 76.0 81.3 82.4 72.2
Access complication 3.5 12.9 10.7 22.9 29.4
Date of access failure/discontinuation 3.3 8.3 12.6 22.1 27.3
BMI – body mass index; PRD – primary renal diagnosis; HD – haemodialysis; PD – peritoneal dialysis; RRT – renal replacement therapy;
AVF – arteriovenous ﬁstula; AVG – arteriovenous graft
Table 12.9. Modality at start of dialysis and access, by referral time, by centre, including surgical referral rates, 2011–2015 data
Early presenters (590 days) % Late presenters (,90 days) % Surg referral % Treatment modality N
Centre PD
AVF/
AVG TL NTL
Total
N PD
AVF/
AVG TL NTL
Total
N Yes No HD PD
Total
N
Antrim 20.2 47.7 12.8 19.3 109 5.3 0.0 31.6 63.2 19 68.0 32.0 111 24 135
B Heart 19.5 48.5 16.0 16.0 462 11.8 23.5 23.5 41.2 17 48.9 51.1 407 96 503
B QEH 24.0 42.9 32.7 0.4 741 9.1 8.6 82.3 0.0 186 65.0 35.0 797 207 1,004
Bangor 26.5 34.7 29.6 9.2 98 10.0 10.0 60.0 20.0 10 67.9 32.1 83 27 110
Basldn 26.7 44.3 19.1 9.9 131 10.5 5.3 10.5 73.7 19 65.4 34.6 121 38 159
Belfast 17.6 32.0 18.9 31.6 244 1.8 0.0 9.1 89.1 55 51.9 48.1 267 46 313
Bradfd 15.4 43.8 30.5 10.3 272 5.6 8.3 41.7 44.4 36 52.8 47.2 274 45 319
Brightn 27.8 35.8 22.6 13.8 486 12.4 4.4 22.1 61.1 113 39.9 60.1 479 153 632
Bristol 19.3 56.0 20.0 4.7 150 6.7 6.7 46.7 40.0 15 85.8 14.2 205 37 242
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Table 12.9. Continued
Early presenters (590 days) % Late presenters (,90 days) % Surg referral % Treatment modality N
Centre PD
AVF/
AVG TL NTL
Total
N PD
AVF/
AVG TL NTL
Total
N Yes No HD PD
Total
N
Camb 11.1 42.7 35.6 10.7 225 6.5 25.8 54.8 12.9 31 63.3 36.7 268 33 301
Cardff 21.4 42.5 34.4 1.6 616 9.1 15.9 75.0 0.0 44 77.1 22.9 563 138 701
Carlis 51.1 13.0 33.7 2.2 92 0.0 8.3 50.0 41.7 12 69.2 30.8 61 48 109
Carsh 0.0 41.8 38.8 19.4 98 0.0 2.9 25.7 71.4 35 0.0 100.0 140 0 140
Chelms 28.5 35.4 28.5 7.6 144 4.3 4.3 39.1 52.2 23 51.4 48.6 135 43 178
Clwyd 9.7 46.8 21.0 22.6 62 0.0 0.0 80.0 20.0 5 66.7 33.3 87 8 95
Colchr 0.0 49.6 50.4 0.0 117 0.0 13.3 73.3 13.3 15 63.9 36.1 162 0 162
Derby 44.9 44.9 8.4 1.8 274 39.5 11.6 37.2 11.6 43 46.7 53.3 186 144 330
Donc 24.2 56.0 9.3 10.4 182 3.4 0.0 20.7 75.9 29 62.9 37.1 176 48 224
Dorset 32.0 45.3 12.8 9.9 172 7.7 0.0 30.8 61.5 39 38.8 61.2 160 59 219
Dudley 30.6 32.9 18.8 17.6 85 13.3 0.0 13.3 73.3 15 56.1 43.9 74 30 104
Exeter 22.6 43.2 15.0 19.2 474 1.0 12.4 5.2 81.4 97 52.9 47.1 496 113 609
Glouc 29.5 43.3 19.5 7.6 210 5.0 0.0 50.0 45.0 20 74.2 25.8 174 63 237
Hull 40.0 27.9 29.6 2.5 365 11.2 3.4 41.6 43.8 89 45.3 54.7 314 163 477
Ipswi 23.1 23.1 53.8 0.0 26 0.0 0.0 100.0 0.0 3 69.6 30.4 26 9 35
Kent 15.3 41.2 43.5 0.0 85 0.0 7.7 84.6 7.7 13 34.8 65.2 92 13 105
L Barts 34.6 21.7 30.0 13.6 806 27.7 4.8 34.6 32.9 231 28.0 72.0 773 364 1,137
L Guys 11.0 42.5 28.0 18.5 200 0.0 4.0 40.0 56.0 25 61.1 38.9 218 22 240
L Kings 22.2 33.8 22.9 21.1 455 11.9 4.5 31.3 52.2 67 43.7 56.3 489 153 642
L Rfree 33.0 32.9 22.9 11.3 764 23.1 2.7 40.1 34.0 147 50.5 49.5 676 301 977
L St.G 19.5 38.4 18.9 23.2 164 0.0 17.9 35.7 46.4 28 58.0 42.0 236 48 284
L West 9.8 13.0 66.0 11.2 1,182 0.0 0.9 45.3 53.8 223 43.2 56.8 1,395 119 1,514
Leic 19.5 42.3 24.1 14.1 771 4.0 5.3 51.7 39.1 151 50.2 49.8 791 160 951
Liv Ain 29.7 49.2 10.3 10.8 195 10.3 3.4 58.6 27.6 29 51.8 48.2 227 74 301
Liv Roy 34.9 33.1 24.0 8.0 175 7.4 18.5 48.1 25.9 27 72.5 27.5 157 64 221
M RI 39.3 35.7 13.6 11.4 140 23.3 3.3 30.0 43.3 30 59.6 40.4 121 65 186
Middlbr 11.3 39.4 34.8 14.4 388 5.9 5.9 36.8 51.5 68 76.9 23.1 442 50 492
Newc 23.3 33.5 32.2 11.0 382 3.3 2.2 65.2 29.3 92 48.7 51.3 392 93 485
Newry 32.1 39.6 16.0 12.3 106 25.0 0.0 8.3 66.7 12 61.9 38.1 89 38 127
Norwch 19.5 42.9 27.3 10.4 77 4.5 13.6 40.9 40.9 22 100.0 0.0 111 25 136
Nottm 33.9 40.4 12.1 13.6 428 22.9 4.2 18.8 54.2 48 44.5 55.5 337 163 500
Oxford 27.5 41.2 19.4 11.9 614 13.0 6.5 45.5 35.1 77 53.5 46.5 546 187 733
Plymth 18.3 42.3 30.3 9.2 142 7.7 7.7 46.2 38.5 26 33.1 66.9 155 40 195
Ports 24.3 38.7 20.1 16.8 641 6.5 10.8 30.1 52.7 93 58.0 42.0 711 178 889
Prestn 19.8 47.3 24.4 8.6 491 5.6 1.9 48.1 44.4 108 52.2 47.8 511 111 622
Redng 39.4 35.5 9.3 15.8 259 11.3 4.2 21.1 63.4 71 31.5 68.5 230 112 342
Salford 25.0 45.0 24.8 5.2 484 12.3 4.6 55.4 27.7 65 42.1 57.9 449 140 589
Sheff 17.9 50.1 21.5 10.5 475 7.7 6.2 41.5 44.6 65 63.7 36.3 486 90 576
Shrew 23.6 35.5 9.1 31.8 110 14.9 14.9 13.5 56.8 74 61.0 39.0 153 42 195
StJms 19.7 47.0 16.2 17.1 538 5.0 3.0 26.7 65.3 101 53.4 46.6 565 113 678
Stevng 14.0 36.4 38.0 11.5 321 3.6 0.0 36.1 60.2 83 50.9 49.1 379 50 429
Sthend 28.8 34.2 27.0 9.9 111 0.0 9.5 28.6 61.9 21 26.8 73.2 110 35 145
Stoke 30.0 47.5 18.0 4.6 217 15.6 6.3 68.8 9.4 32 69.1 30.9 246 100 346
Sund 16.0 39.1 36.6 8.4 238 2.9 0.0 52.9 44.1 34 65.5 34.5 247 41 288
Swanse 23.1 44.6 9.5 22.8 451 9.6 8.7 8.7 73.1 104 39.5 60.5 461 116 577
Truro 19.7 37.5 31.6 11.2 152 0.0 0.0 45.7 54.3 46 48.4 51.6 184 36 220
Ulster 12.7 38.0 34.2 15.2 79 4.2 12.5 54.2 29.2 24 65.5 34.5 97 13 110
West NI 21.0 33.9 30.6 14.5 62 0.0 0.0 60.0 40.0 5 52.2 47.8 55 14 69
Wirral 23.8 39.7 15.2 21.2 151 9.1 3.0 24.2 63.6 33 43.4 56.6 157 42 199
Wolve 37.2 31.0 28.3 3.5 339 36.5 5.8 51.9 5.8 52 50.6 49.4 258 149 407
Wrexm 28.3 33.1 18.6 20.0 145 0.0 0.0 23.1 76.9 13 56.1 43.9 123 42 165
York 28.2 49.4 10.6 11.8 170 12.5 0.0 35.0 52.5 40 53.4 46.6 172 57 229
Total 23.8 38.1 26.2 11.9 18,343 10.1 5.6 39.8 44.6 3,350 52.8 47.2 18,607 5,032 23,639
Surg – surgical; PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line; NTL – non-tunnelled line
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minimum guideline standards. Direct year-to-year com-
parisons in performance are not valid due to annual
changes in centres providing data and quality of data
completion. A secondary analysis including only centres
that have reported continuously from 2012 to 2015
(data not shown), shows that for these centres the trend
was similar to the results in table 12.10.
Table 12.11 shows dialysis access three months after
initiation, stratiﬁed by ﬁrst access used for patients
from the 2011–2015 audits. This reproduces table 12.6
(which includes 2015 patients only). As before, the
majority (85.8%) of patients who initiated with deﬁnitive
access continued with deﬁnitive access or had been trans-
planted at three months. Of patients who started dialysis
without deﬁnitive access, 28.4% received a transplant or
were dialysing with deﬁnitive access at three months.
Death before three months was much more common in
patients initiating dialysis with a NTL than with any
other form of initial access (12.7%), which is lower than
the 2015 data (22.4%).
Figures 12.20–12.25 replicate ﬁgures 12.2–12.7 (2015
incident patients only) to include all incident patients
from 2011–2015. The trends described in ﬁgures 12.2–
12.7 are largely reproduced. Data completeness for BMI
and diabetic status remained low with multiple centre-
level exclusions.
Figure 12.26 plots the incident RRT approach stratiﬁed
by centre and reproduces ﬁgure 12.8 (2015 data only) for
incident RRT patients from 2011–2015. The most notable
feature is centre-to-centre variation in rates of PD as an
incident modality. Use of PTx appears less strongly
associated with centre size than for 2015 data.
Table 12.10. Annual rates of deﬁnitive access and pre-emptive transplantation and concordance with Renal Association audit
standards
Modality in incident and prevalent patients 2011 2012 2013 2014 2015 Audit standard
Incident patients
Deﬁnitive access (AVF/AVG/PD) or PTx in incident RRT patients (%) 56.5 57.6 58.7 56.5 55.3 None set
Deﬁnitive access (AVF/AVG/PD) or PTx in incident RRT patients excluding
late presenters (%)
62.9 63.4 64.8 62.6 61.4 None set
AVF/AVG in incident HD patients (%) 41.4 40.9 41.8 39.2 38.6 None set
AVF/AVG in incident HD patients, excluding late presentation (%) 48.3 47.4 48.4 45.6 45.2 60%
AVF/AVG/PD in incident dialysis patients (%) 53.0 54.0 54.6 52.2 51.7 None set
AVF/AVG/PD in incident dialysis patients excluding late presentation (%) 59.5 59.9 60.8 58.3 57.8 None set
Prevalent patients
Deﬁnitive access (AVF/AVG/PD) in prevalent dialysis patients (%) ∗ 82.3 79.0 73.6 72.6 80%
AVF/AVG in prevalent HD patients (%) ∗ 79.0 75.4 69.6 68.6 None set
In 2015, audit standards were updated for AVF/AVG in incident HD patients (minimum standard reduced from 65% to 60%); incident
RRT recipients (to include PD and PTx; no minimum standard set) and prevalent dialysis patients (to include PD and HD via AVF/AVG –
‘deﬁnitive access’, minimum standard 80%). It is not entirely the same centres submitting access data each year and therefore direct year-to-
year comparisons in performance are not valid.
HD – haemodialysis; PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line; NTL – non-
tunnelled line; RRT – renal replacement therapy
∗Prevalent data were not collected in the 2011 audit
Table 12.11. Type of dialysis access at 90 days stratiﬁed by initial modality in 2011–2015
Access in use at
ﬁrst dialysis (N)
Access in use at three months (%)
AVF/AVG TL NTL PD catheter Tx Died Stop/LTFU Recovered Missing
AVF/AVG (7,494) 85.3 4.5 0.1 0.3 1.0 3.2 0.3 0.6 4.8
TL (6,900) 10.7 75.8 0.3 2.7 1.0 5.8 0.5 0.0 3.3
NTL (4,213) 8.2 64.1 4.7 5.5 0.3 12.7 0.8 0.0 3.7
PD (5,032) 0.5 5.6 0.3 84.2 1.9 2.0 0.3 0.0 5.3
Shaded cells highlight the percentage of patients who remained on the same modality at three months
PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; Tx – transplant; TL – tunnelled line; NTL – non-tunnelled
line; LTFU – lost to follow-up
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Fig. 12.20. Percentage of incident RRT
patients stratiﬁed by age and access at start,
2011–2015
Number of patients in each group in brackets.
PTx – pre-emptive transplant; PD – peritoneal
dialysis; AVF – arteriovenous ﬁstula;
AVG – arteriovenous graft; TL – tunnelled line;
NTL – non-tunnelled line
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Fig. 12.21. Percentage of incident dialysis
patients stratiﬁed by BMI and access at start,
2011–2015
Number of patients in each group in brackets.
PD – peritoneal dialysis; AVF – arteriovenous
ﬁstula; AVG – arteriovenous graft; TL – tunnelled
line; NTL – non-tunnelled line; BMI – body mass
index
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Fig. 12.22. Percentage of incident RRT
patients stratiﬁed by PRD and access at start,
2011–2015
Number of patients in each group in brackets.
PRD groups are sorted by decreasing proportion
of patients initiating RRT with a HD catheter.
PRD – primary renal diagnosis; DM – diabetes
mellitus; GN – glomerulonephritis; HTN –
hypertension; PKD – polycystic kidney disease;
Pyelo – pyelonephritis; RVD – renal vascular
disease
PTx – pre-emptive transplant; PD – peritoneal
dialysis; AVF – arteriovenous ﬁstula;
AVG – arteriovenous graft; TL – tunnelled line;
NTL – non-tunnelled line
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Fig. 12.23. Percentage of incident RRT
patients stratiﬁed by length of time known to
nephrology and access at start, 2011–2015
Number of patients in each group in brackets.
PTx – pre-emptive transplant; PD – peritoneal
dialysis; AVF – arteriovenous ﬁstula;
AVG – arteriovenous graft; TL – tunnelled line;
NTL – non-tunnelled line
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Fig. 12.24. Percentage of incident RRT
patients by diabetic status and access at start,
2011–2015
Number of patients in each group in brackets.
PTx – pre-emptive transplant; PD – peritoneal
dialysis; AVF – arteriovenous ﬁstula;
AVG – arteriovenous graft; TL – tunnelled line;
NTL – non-tunnelled line
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Fig. 12.25. Percentage of incident dialysis
patients by assessment by a surgeon within
3 months before starting RRT and access at
start of dialysis, 2011–2015
Number of patients in each group in brackets.
Late presenting patients were excluded from the
analysis.
AVF – arteriovenous ﬁstula; AVG –
arteriovenous graft; TL – tunnelled line; NTL –
non-tunnelled line; PD – peritoneal dialysis
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Fig. 12.26. Incident RRT approach for patients in the 2011–2015 Multisite Dialysis Access audits, stratiﬁed by renal centre
Centre size (patient numbers) in brackets. Centres are stratiﬁed by transplant/non-transplant centre and sorted by proportion of patients initiating HD
with a TL/NTL. PTx – pre-emptive transplant; PD – peritoneal dialysis; AVF – arteriovenous ﬁstula; AVG – arteriovenous graft; TL – tunnelled line;
NTL – non-tunnelled line; RRT – renal replacement therapy
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Discussion
In this ﬁfth annual multisite dialysis access audit,
information is presented on the nature, timeliness and
durability of initial dialysis access for 23,639 incident
RRT patients. This accounts for 71.6% of patients starting
dialysis in England, Wales and Northern Ireland over this
period. These data describe national and centre-level
performance and identify patient and system factors
that are associated with practice patterns. The centres
contributing data to the audit have changed, so it is not
appropriate to make direct year-to-year comparisons.
However, deﬁnitive access amongst both incident and
prevalent patients was below Renal Association audit
standards for nearly every year of the data collection.
There were a small number of centres achieving high
rates of deﬁnitive dialysis access for incident and preva-
lent dialysis recipients, demonstrating that the audit stan-
dards are attainable. In addition, the Dialysis Outcomes
and Practice Patterns Study (DOPPS) suggests that the
UK is improving in overall performance [3]. A better
understanding of the practice patterns at high performing
centres has the potential to provide information to
inform wider quality improvement.
This audit conﬁrms that timely presentation to a
nephrologist and referral to a dialysis access surgeon
are associated with higher rates of deﬁnitive dialysis
access use. Most patients who only meet a nephrologist
for the ﬁrst time within three months of starting dialysis
commenced HD via a NTL/TL. However, a substantial
proportion of patients known to a nephrologist for
more than three months also commenced HD via this
form of access, and indeed conversion from a NTL/TL
to deﬁnitive access by three months was infrequent in
most centres. The need to begin access planning early is
conﬁrmed by the observation that 86.3% of individuals
who had access attempted more than a year before initi-
ating HD, started with an AVF/AVG. A small number of
centres were however, able to secure deﬁnitive access
within three months, achieved in part by promoting the
use of PD. Most commonly, responsive PD access path-
ways were achieved through the use of the percutaneous
rather than surgical catheter insertion pathways. This is
logical, since this approach is generally performed
under local anaesthetic, avoiding the requirement for
both scheduling a pre-operative assessment and operat-
ing theatre time. No evidence was found in this audit to
suggest percutaneous placement of PD catheters was
inferior to surgical placement, since catheter function at
one year was similar for all insertion techniques. A
number of centres were able to achieve rapid surgical
pathways for vascular access. Again, efforts to better
understand practice patterns that enhance the respon-
siveness of vascular and PD access services are needed.
Results from the UK Peritoneal Dialysis Outcomes and
Practice Patterns Study (PDOPPS) Catheter Study [4]
and a national survey of HD access in the UK by the
British Renal Society Vascular Access Special Interest
Group will inform practice.
It has been argued that lower rates of deﬁnitive dialysis
access in some centres may be a result of higher rates of
PTx, because these patients may otherwise have started
dialysis with deﬁnitive access. For this reason, PTx data
are included alongside the dialysis access data in some
places and allocated patients to centres according to the
catchment area of the dialysis centre, rather than the
transplant centre that they ﬁrst appeared in. These data
were therefore provided to explore the impact of pre-
emptive and early transplant on dialysis access rates
and were not intended as a study of variation in rates
of transplantation. Importantly, there was no strong
evidence to demonstrate that deﬁnitive dialysis access
use was inﬂuenced by transplant/non-transplant centre
status, or by the proportion of patients receiving PTx at
centre level. Previous versions of this chapter have
noted counterintuitive associations between increasing
age and BMI with AVF/AVG use. The increased propor-
tional use of AVF/AVG with increasing age and BMI
reﬂect the lower use of PD and transplantation amongst
older people and the obese. It is presumably for the same
reason that the proportional use of TL/NTL amongst
incident RRT recipients increased with age and BMI.
Inclusion of PTx data has also highlighted the prominent
differences in practice patterns between primary renal
diagnoses. For example, rates of PTx and deﬁnitive access
were particularly high for people with polycystic kidney
disease. People with this primary diagnosis were likely
to be known to nephrologists for several years prior to
starting RRT and to have enhanced health literacy due
to the familial nature of the condition – both factors
that increase the opportunity for preparation for RRT.
Understanding the factors that contribute to success in
this group may allow effective components of the
access pathway to be disseminated. Further unexplained
patterns remain that require exploration, such as lower
rates of AVF/AVG use amongst individuals whose ethni-
city was listed as Black and the low use of deﬁnitive access
in patients with BMI ,20.
The UKRR has an important role in monitoring the
quality of planned and unplanned RRT provision and
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informing guidance and practice improvement. Centre-
level data are provided as a surrogate of geographical
variation in RRT provision. Wide variation in practice
reﬂects the absence of a cohesive approach, despite
national guidance. The insights gained from the inclusion
of all information about all three RRT modalities in this
chapter reﬂect the importance of a comprehensive
approach in the exploration of trends in RRT access
provision. Once again, this year’s multisite dialysis access
audit identiﬁes the need for research and quality
improvement initiatives to enhance dialysis access prac-
tice. The following approaches may help to generate the
knowledge required to drive this process:
. Detailed practice pattern assessment of high and
low-performing centres and those that have demon-
strated marked improvement in their delivery of
deﬁnitive access.
. Assessment of responsive pathways to PD access
formation, with particular focus on the role of
surgical and non-surgical insertion technique and
treatment pathways that facilitate initiation of PD
within 90 days.
. Use of UKRR data to analyse the associations
between dialysis access at initiation and outcomes
beyond one year, including dialysis catheter-related
complications.
. Improvement in the completeness of data provision
for the annual multisite dialysis access audit.
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